| Bioactivity | Vilzemetkib (compound I) is a c-Met kinase inhibitor that can be used to inhibit neurofibromatosis type I[1]. |
| CAS | 1363402-44-1 |
| Formula | C36H36F2N4O5 |
| Molar Mass | 642.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Use of compound as c-Met kinase inhibitor for treatment of neurofibromatosis type I. World Intellectual Property Organization, WO2022268158 A1 2022-12-29. |